Dr. Jennifer Walden’s dedication to her chosen field can be seen as early as her college years. Her commitment to her studies earned her the privilege of being chosen as salutatorian of her graduating class from the medical extension of the University of Texas. Prior to that, she had graduated from the University of Texas with honors after obtaining her Bachelor’s degree in biology. The dedication she exhibited to her studies also earned her an educational scholarship from the Vaughn Foundation for the years of 1995, 96 and 97. After that she went on to receive more scholarships and awards for her continuing educational efforts.
After graduating with high honors from the University of Texas’s medical branch, Dr. Jennifer Walden was offered a fellowship at the Manhattan Eye, Ear and Throat Hospital in New York. Although this meant leaving her hometown of Austin, she chose to accept the position, which propelled her on her way toward a career in plastic surgery. She also decided to specialize in the field of cosmetic surgery, which led her to contribute articles on topics of relevance within her field to numerous publications, some of which led to live conference presentations.
Although Dr. Walden has been a leading figurehead in the field of cosmetic surgery, she still retains a down to earth manner with her patients. Currently operating her own clinic back in her hometown of Austin, Texas, she assists patients with procedures that range from breast augmentations to Botox injections. She operates her clinic with a focus on providing high quality patient service, which includes making sure patients receive the information needed to make better choices about the procedures they want performed. The clinic also offers a relaxed atmosphere to help put patients at ease. Dr. Jennifer Walden’s patients have often described her as being friendly, knowledgeable, compassionate and generally amazing.
Jennifer Walden is from Austin, and the second in her class at Galveston’s University of Texas Medical Branch. After she finished her fellowship in aesthetic surgery at Manhattan’s Eye, Ear, and Throat Hospital, she successfully built her practice in New York. After that she returned back home in 2011.
According to Dr. Walden, for eight years she has been working as a plastic surgeon. Her concentration and expertise are on nose jobs (rhinoplasties), eyelid lifts, face-lifts, breast augmentations, and cosmetic surgery. The expenses for a nose job are usually between $8,000 to $9,000, face lifts costs about $10,000, and augmentation are normally around $7,000. She also does liposuction on the arms, inner thighs, and on the abdomen along with negligible invasive operations like soft-tissue fillers and Botox injecting.
Dr. Jennifer Walden says that she is unusual because there are more men than women who choose a career in plastic surgery, as proven by the country’s board-certified plastic surgeons where 851 are female out of 8,100. And these certified professionals American Society for Aesthetic Plastic Surgery members – a prominent and reputable board-certified cosmetic surgeons’ organization, and only 12 reside in Texas.
Moreover, she said that a plastic surgeon who is a woman has some benefits since most plastic surgery patients are women. She explains that women who go for plastic surgery do not have the intention of duplicating a Barbie doll. The go for plastic surgery due to the fact that they are self-conscious about a saggy body part or another normal body feature. She claims that her clients tell her they are more comfortable talking to a female plastic surgeon about particular parts of their bodies because she will not criticize them unnecessarily.
Dr. Walden says that she is happy when she knows that she was, and is able to help other people, especially her own gender.
Learn More: www.healthgrades.com/physician/dr-jennifer-walden-x7hp3
Dr. Rod J Rohrich has been a leading force in the plastic surgery and rhinoplasty industry for decades. He has received numerous awards as a top professional in the past few years:
In 2013 the US New and World Report rankings honored Dr. Rohrich as being a part of the top 15 of physicians in the USA. Not only a top surgeon in his specialty, but nationally recognized as a leading physician across all practices.
In 2015 Plastic Surgeons USA named him as one of the best in the practice. The honor is awarded after conducting a thorough series of peer reviews to find the best in the business and support customer decision making when seeking a surgeon. Speaking about the honor Dr. Rohrich stated “This award is meaningful in part because it is driven by peer nomination and is an important component of reliable medical information.”
Also in 2015 D Magazine recognized Dr. Rohrich for his excellent work in the cosmetic nasal surgery and nasal reconstruction practices. He also helps serve in his community outside of his practice, by helping develop the next generation of surgeons. He is currently teaching at the Departing of Plastic Surgery at UT Southwestern Medical Center as a distinguished professor. You can visit his profile at UT Southwestern to learn more about his education, publications and clinical interests –
Currently serving as the Chairman for the Dallas Rhinoplasty Symposium, he led the 33rd annual event in March 2016. The symposium offers attendees a chance to meet other professional in their practice, gain experience under Dr. Rohrich, lectures, Q&A sessions, and panel discussions. Speaking on the journal Rohrich stated “The Dallas Rhinoplasty Symposium provides access to information and advances that are truly on the forefront of this specialized area.”
The doctor also helps give back to his profession through publication. He co-authored “Dallas Rhinoplasty: Nasal Surgery by the Masters” based on a series of presentations from past symposium events. He has also served as the editor of the ‘Plastic and Reconstructive Surgery Journal’ for the past 10 years which serves as a part of surgeons’ continuing medical education.
As a leading practitioner in this field he has presented over 2,000 times and led over 6,000 plastic surgeries during his career. You can visit his official website at for additional information on his career achievements, authored works and social media details. Follow Rohrich
There has been an alarming amount of cancer survivors and the number continues to grow each year. Research and development have helped to expand technology improvements related to cancer treatments. The past 30 years have shown a large increase in the cancer survivor category by millions. In 2016, it was reported that there were approximately 15.5 million people who experienced successful cancer therapy. It’s estimated by 2040 those numbers will reach 26.1 million. People who are in remission have many different needs than most of us. They have to make sure that they continue to monitor the effects of treatment, continue with their scans and take certain medications.
Eric Lefkofsky is the co-founder and CEO of Tempus. He has dedicated much of his career to cancer research and detailed studies. As a successful entrepreneur, Lefkofsky created Tempus to help develop innovative and popular cancer treatments. Tempus helps work with many physicians and healthcare professionals by using cutting-edge technology utilizing genomic sequencing and methods of analysis. These are used to understand the necessary details needed to properly treat a patient’s tumor. By gathering large amounts of information and data, Tempus is able to better assist physicians so they are able to treat their patient’s properly. They can prescribe a more intense and personalized approach to therapy by utilizing high scaled technology. The data collected from Tempus is relayed to help doctors promote a more advanced plan of care and treatment for each patient.
Lefkofsky and his wife are fully engaged in the industry of cancer research. They regularly donate to research causes and have created a foundation called the Lefkofsky Family Foundation. They donated $1 million to the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Other donations have been made to give support to immunotherapy in relation to gastric cancer and breast cancer. He is also involved in The Giving Pledge and serves as a Trustee at Lurie Children’s Hospital of Chicago. As an entrepreneur, he has committed a lifetime of research to help those who are diagnosed with cancer. His future hope is to help those recover from the disease and remain in remission for a lifetime. With technology on the rise and a rapid growth with research, the success of survivors is increasing at a rapid rate.